Literature DB >> 12702876

Induction of tumors in mice by genomic hypomethylation.

François Gaudet1, J Graeme Hodgson, Amir Eden, Laurie Jackson-Grusby, Jessica Dausman, Joe W Gray, Heinrich Leonhardt, Rudolf Jaenisch.   

Abstract

Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 (Dnmt1) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702876     DOI: 10.1126/science.1083558

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  490 in total

1.  Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate.

Authors:  Sachin S Bhusari; Joseph R Dobosy; Vivian Fu; Nima Almassi; Terry Oberley; David F Jarrard
Journal:  Epigenetics       Date:  2010-07-01       Impact factor: 4.528

Review 2.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

3.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Authors:  F Neri; D Dettori; D Incarnato; A Krepelova; S Rapelli; M Maldotti; C Parlato; P Paliogiannis; S Oliviero
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

4.  Genes and transposons are differentially methylated in plants, but not in mammals.

Authors:  Pablo D Rabinowicz; Lance E Palmer; Bruce P May; Michael T Hemann; Scott W Lowe; W Richard McCombie; Robert A Martienssen
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

5.  The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin.

Authors:  Taiping Chen; Naomi Tsujimoto; En Li
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 6.  DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.

Authors:  Jian Tajbakhsh
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

7.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Ju-Seog Lee; Elizabeth A Conner; Insa Schroeder; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 9.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

10.  Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.

Authors:  Marinus R Heideman; Roel H Wilting; Eva Yanover; Arno Velds; Johann de Jong; Ron M Kerkhoven; Heinz Jacobs; Lodewyk F Wessels; Jan-Hermen Dannenberg
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.